These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
358 related articles for article (PubMed ID: 29174692)
1. Increased serum production of soluble CD163 and CXCL5 in patients with moyamoya disease: Involvement of intrinsic immune reaction in its pathogenesis. Fujimura M; Fujimura T; Kakizaki A; Sato-Maeda M; Niizuma K; Tomata Y; Aiba S; Tominaga T Brain Res; 2018 Jan; 1679():39-44. PubMed ID: 29174692 [TBL] [Abstract][Full Text] [Related]
2. Importance of RNF213 polymorphism on clinical features and long-term outcome in moyamoya disease. Kim EH; Yum MS; Ra YS; Park JB; Ahn JS; Kim GH; Goo HW; Ko TS; Yoo HW J Neurosurg; 2016 May; 124(5):1221-7. PubMed ID: 26430847 [TBL] [Abstract][Full Text] [Related]
3. RNF213 rs112735431 polymorphism in intracranial artery steno-occlusive disease and moyamoya disease in Koreans. Park MG; Shin JH; Lee SW; Park HR; Park KP J Neurol Sci; 2017 Apr; 375():331-334. PubMed ID: 28320162 [TBL] [Abstract][Full Text] [Related]
4. Genetic analysis of Tashiro R; Fujimura M; Sakata H; Endo H; Tomata Y; Sato-Maeda M; Niizuma K; Tominaga T Neurol Res; 2019 Sep; 41(9):811-816. PubMed ID: 31064275 [No Abstract] [Full Text] [Related]
5. Temporal profile of magnetic resonance angiography and decreased ratio of regulatory T cells after immunological adjuvant administration to mice lacking RNF213, a susceptibility gene for moyamoya disease. Kanoke A; Fujimura M; Niizuma K; Fujimura T; Kakizaki A; Ito A; Sakata H; Sato-Maeda M; Kure S; Tominaga T Brain Res; 2016 Jul; 1642():1-9. PubMed ID: 26972532 [TBL] [Abstract][Full Text] [Related]
6. The Role of RNF213 4810G>A and 4950G>A Variants in Patients with Moyamoya Disease in Korea. Park YS; An HJ; Kim JO; Kim WS; Han IB; Kim OJ; Kim NK; Kim DS Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29160859 [TBL] [Abstract][Full Text] [Related]
7. Differing phenotypes of Moyamoya disease in a familial case involving heterozygous c.14429G > A variant in RNF213. Inoue T; Murakami N; Sakadume S; Kido Y; Kikuchi A; Ichinoi N; Suzuki K; Kure S; Sakuta R Pediatr Int; 2015 Aug; 57(4):798-801. PubMed ID: 26315205 [TBL] [Abstract][Full Text] [Related]
8. Association between the rs112735431 polymorphism of the RNF213 gene and moyamoya disease: A case-control study and meta-analysis. Huang Y; Cheng D; Zhang J; Zhao W J Clin Neurosci; 2016 Oct; 32():14-8. PubMed ID: 27515544 [TBL] [Abstract][Full Text] [Related]
9. Cav-1 (Caveolin-1) and Arterial Remodeling in Adult Moyamoya Disease. Chung JW; Kim DH; Oh MJ; Cho YH; Kim EH; Moon GJ; Ki CS; Cha J; Kim KH; Jeon P; Yeon JY; Kim GM; Kim JS; Hong SC; Bang OY Stroke; 2018 Nov; 49(11):2597-2604. PubMed ID: 30355208 [TBL] [Abstract][Full Text] [Related]
10. Frequency and significance of rare RNF213 variants in patients with adult moyamoya disease. Jang MA; Chung JW; Yeon JY; Kim JS; Hong SC; Bang OY; Ki CS PLoS One; 2017; 12(6):e0179689. PubMed ID: 28617845 [TBL] [Abstract][Full Text] [Related]
11. RNF213 as the major susceptibility gene for Chinese patients with moyamoya disease and its clinical relevance. Zhang Q; Liu Y; Zhang D; Wang R; Zhang Y; Wang S; Yu L; Lu C; Liu F; Zhou J; Zhang X; Zhao J J Neurosurg; 2017 Apr; 126(4):1106-1113. PubMed ID: 27128593 [TBL] [Abstract][Full Text] [Related]
12. Vascular tortuosity of the internal carotid artery is related to the RNF213 c.14429G > A variant in moyamoya disease. An S; Kim T; Oh CW; Bang JS; Lee SU; Heo J Sci Rep; 2019 Jun; 9(1):8614. PubMed ID: 31197213 [TBL] [Abstract][Full Text] [Related]
13. Temporal profile of the vascular anatomy evaluated by 9.4-tesla magnetic resonance angiography and histological analysis in mice with the R4859K mutation of RNF213, the susceptibility gene for moyamoya disease. Kanoke A; Fujimura M; Niizuma K; Ito A; Sakata H; Sato-Maeda M; Morita-Fujimura Y; Kure S; Tominaga T Brain Res; 2015 Oct; 1624():497-505. PubMed ID: 26315378 [TBL] [Abstract][Full Text] [Related]
14. Genetic Analysis of RNF213 c.14576G>A Variant in Nonatherosclerotic Quasi-Moyamoya Disease. Miyawaki S; Imai H; Shimizu M; Yagi S; Ono H; Nakatomi H; Shimizu T; Saito N J Stroke Cerebrovasc Dis; 2015 May; 24(5):1075-9. PubMed ID: 25817623 [TBL] [Abstract][Full Text] [Related]
15. Rare variants of RNF213 and moyamoya/non-moyamoya intracranial artery stenosis/occlusion disease risk: a meta-analysis and systematic review. Liao X; Deng J; Dai W; Zhang T; Yan J Environ Health Prev Med; 2017 Nov; 22(1):75. PubMed ID: 29165161 [TBL] [Abstract][Full Text] [Related]
16. Moyamoya Disease and Spectrums of RNF213 Vasculopathy. Bang OY; Chung JW; Kim DH; Won HH; Yeon JY; Ki CS; Shin HJ; Kim JS; Hong SC; Kim DK; Koizumi A Transl Stroke Res; 2020 Aug; 11(4):580-589. PubMed ID: 31650369 [TBL] [Abstract][Full Text] [Related]
17. [Precision Medicine for Moyamoya Disease]. Fujimura M No Shinkei Geka; 2022 Jan; 50(1):216-221. PubMed ID: 35169101 [TBL] [Abstract][Full Text] [Related]
18. De Novo Development of Moyamoya Disease in an Adult Female with a Genetic Variant of the RNF-213 Gene: Case Report. Tashiro R; Fujimura M; Niizuma K; Endo H; Sakata H; Sato-Maeda M; Tominaga T J Stroke Cerebrovasc Dis; 2017 Jan; 26(1):e8-e11. PubMed ID: 27789153 [TBL] [Abstract][Full Text] [Related]
19. Temporal profile of the vascular anatomy evaluated by 9.4-T magnetic resonance angiography and histopathological analysis in mice lacking RNF213: a susceptibility gene for moyamoya disease. Sonobe S; Fujimura M; Niizuma K; Nishijima Y; Ito A; Shimizu H; Kikuchi A; Arai-Ichinoi N; Kure S; Tominaga T Brain Res; 2014 Mar; 1552():64-71. PubMed ID: 24440776 [TBL] [Abstract][Full Text] [Related]
20. De Novo Development of Moyamoya Disease after Stereotactic Radiosurgery for Brain Arteriovenous Malformation in a Patient With RNF213 p.Arg4810Lys (rs112735431). Torazawa S; Miyawaki S; Shinya Y; Kawashima M; Hasegawa H; Dofuku S; Uchikawa H; Kin T; Shin M; Nakatomi H; Saito N World Neurosurg; 2020 Aug; 140():276-282. PubMed ID: 32434013 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]